Introduction
Activation of potassium (K + ) fluxes across the inner mitochondrial membrane (IMM) is a key mechanism for cardiac ischaemic preconditioning. 1 Under physiological conditions, the IMM is poorly permeable to K + ions as mitochondrial K + (mitoK) channels are mostly closed. However, during ischaemia, different triggers activate mitoK channels, leading to significant influx of K + ions, accompanied by water and anions, resulting in matrix swelling and depolarization of the membrane potential. As such, the activation of mitoK channels controls the matrix volume, preserving a narrow intermembrane space, necessary for an effective oxidative phosphorylation, and opposes Ca 2+ -overload and subsequent opening of the mitochondrial permeability transition pore, a powerful trigger of apoptosis. 1 In cardiac cells, pharmacological activation of mitochondrial ATP-sensitive (mitoK ATP ) and largeconductance Ca 2+ -activated (mitoBK Ca ) K + channels 2 -4 triggers cardioprotective responses in different models of ischaemia/reperfusion (I/R) injury. 3,5 -7 Other K + channel subtypes have been described in the IMM of mostly non-cardiac cells. 8 Despite these studies, molecular identification of cardiac mitoK channels heterogeneity is far from being complete.
Voltage-gated K + channels encoded by the Kv7 gene family (Kv7.1-7.5, also known as KCNQ1-5) have well-defined expression patterns and functional roles in heart, neurons, epithelia, and vascular and nonvascular smooth muscle. 9 In brain and sensory neurons, Kv7.2/7.3 or 7.3/7.5 heteromers contribute to a subthreshold current called M-current, whereas Kv7.4 and/or Kv7.5 channels, together with Kv7.1, appear to be major determinants of cellular excitability in vascular and non-vascular smooth muscle cells. 10 In cardiac cells, Kv7.1 encodes for subunits contributing to the slowly repolarizing current IK s ; 11 however, significant levels of Kv7.4 transcripts have also been reported in the heart, 12 but no function ascribed.
To date, all functional roles of Kv7 channels have been attributed to their plasma membrane location and regulations of cellular membrane potential, although their possible impact on mitochondrial physiology has not been determined. In this study, we report biochemical and morphological evidence for the presence of Kv7.4 subunits in cardiac mitochondria, also defining their contribution to mitochondrial function. In addition, we show that the pharmacological activation of these channels exerts significant cytoprotective effects in mitochondrialdependent in vitro and ex vivo models of cardiac I/R damage, suggesting that targeting mitoKv7.4 channels might be an effective strategy for cardioprotection against I/R cardiac injury.
Methods
Only a general overview of key methods is provided here; see Supplementary material online for further experimental details.
Animals
Male rats of 2 -3 months of age were used. Experimental procedures were carried out following the guidelines of the Directive 2010/63/EU of the European Parliament and have been approved by the Committee for animal experimentation of the institutions in which experiments were carried out.
RNA extraction and quantitative real-time PCR
Total RNA from rat brains, livers, and hearts was isolated and reversetranscribed to cDNA; quantitative polymerase chain reaction (qPCR) was carried out in a real-time PCR system using the SYBR Green detection technique and specific primers (Supplementary material online, Table S1 ).
Isolation of rat primary cardiomyocytes
Dissected rat hearts were perfused in the Langendorff mode with collagenase. Isolated cells were resuspended in Ca 2+ -Tyrode solution, spread on laminin-coated cover slips, and allowed to adhere for 8 h before further processing.
Cell cultures and transfection
H9c2 cells from embryonic rat ventricular myocytes and Chinese hamster ovary (CHO) cells were used in the present experiments; cells were transfected using Lipofectamine.
Immunofluorescence
H9c2 cells or primary cardiomyocytes were incubated with Mitotracker w Red, fixed with paraformaldehyde, and then incubated with primary antibodies. Rat hearts were fixed in paraformaldehyde and incubated in sucrose for cryopreservation at 2808C; frozen sections (20 mm) were cut and stored at 2208C until further processing. Following incubation with primary and secondary antibodies, cells and cardiac slices were counterstained with Hoechst 33 258 to visualize cell nuclei and analysed using a Zeiss LSM 510 Meta argon/krypton laser scanning confocal microscope.
Pre-embedding immunogold electron microscopy
Rat heart coronal vibrosections were incubated with the primary Kv7.4 monoclonal antibody and then with a 1.4 nm gold-labelled antibody directed towards mouse IgG. Ultrathin sections containing silver-intensified gold particles were osmicated, dehydrated, embedded in Epon resin 812, and examined in a PHILIPS EM208S electron microscope.
Mitochondria isolation
Rat cardiac and hepatic mitochondria were isolated by differential centrifugation 13 ; mitochondria from H9c2 cells and primary adult rat cardiomyocytes were obtained using a commercially available kit. Mitoplasts were prepared using the detergent digitonin.
Western blots
Protein samples for western blot experiments were loaded on 8 or 8 -15% sodium dodecyl sulphate -polyacrylamide gel electrophoresis and then transferred to a polyvinylidene fluoride membrane. Membranes were incubated with primary and secondary antibodies and reactive bands detected by chemiluminescence. Kv7.4 channels in rat cardiac mitochondria assessed using the fluorescent dyes tetramethyl rhodamine ethyl ester (TMRE), X-Rhod, and MitoSOX Red, respectively. Images from TMRE and X-Rhod experiments were recorded by a conventional immunofluorescence imaging system; those from MitoSOX red were acquired using confocal microscopy.
Silencing Kv7.4 expression by shRNA in H9c2 cells
H9c2 cells were transiently transfected with a plasmid encoding for a short hairpin RNA (shRNA) directed against Kv7.4 mRNA (pLKO.1-shKv7.4) or with a control plasmid carrying a nonsense sequence (pLKO.1-scramble). The procedure has been previously used in our laboratory to selectively suppress Kv7.4 expression in C2C12 mouse skeletal myoblasts; Kv7.4 silencing was assessed by western blotting experiments. 15 2.12 Anoxia/re-oxygenation (A/R) in H9c2 cells
To simulate anoxia in H9c2 cells, plated cells were exposed to a lowglucose and serum-free solution and sealed for 16 h in airtight containers saturated with 95% N 2 and 5% CO 2 (378C), whereas twin plates were placed in 95% air and 5% CO 2 (normoxic conditions). Then, cells were subjected to re-oxygenation for 2 h in an atmosphere containing 95% air and 5% CO 2 (378C). After re-oxygenation, cell viability was assessed.
Langendorff-perfused rat hearts
Rat hearts were quickly removed, mounted on a Langendorff apparatus, and perfused with oxygenated solution at 378C and constant pressure (70 -80 mmHg). 16 A water-filled latex balloon connected to a pressure transducer was introduced into the left ventricle to achieve a stable left ventricular end-diastolic pressure of 5 -10 mmHg. The functional parameters of heart rate (HR), left ventricular developed pressure (LVDP), and the rate of rise of the left ventricular pressure (dP/dt) were monitored continuously. Rate pressure product (RPP) was calculated as HR × LVDP. Coronary flow (CF) was also estimated. After 20 min of equilibration, 30 min of global ischaemia (no flow) followed. At the end of the ischaemic period, the hearts were reperfused for 2 h; following reperfusion, hearts were removed from the Langendorff apparatus, and 2 mm large slices cut from the left ventricle were immersed in a solution containing 2,3,5-triphenyltetrazolium chloride to evaluate the extension of the damage.
Drugs and antibodies
Retigabine and flupirtine were from Valeant (Laval, Canada); XE991, oligomycin, 2,4-dinitrophenol, valinomycin, and FCCP were from Sigma-Aldrich (Milan, Italy). The primary antibodies used were: (i) mouse monoclonal Kv7.4 (UC Davis/NIH NeuroMab Facility, USA; clone N43/6.1; dilution: 1:100 for immunofluorescence and electron microscopy; 1:500/1000 for western blot); (ii) rabbit polyclonal sphingosine 1-phosphate receptor 1 (S1PR1, 1:500; Abcam, Cambridge, UK); (iii) mouse monoclonal Kv7.1 (1:500; NeuroMab, clone N37A/10.1, used for western blot); (iv) rabbit Kv7.1 (1:100; Millipore, Temecula, USA, used for immunocytochemistry); (v) mouse VDAC1 (TC supernatant, 1:5, NeuroMab); (vi) mouse a-tubulin antibody (1:5000; Sigma-Aldrich); (vii) mouse glyceraldehyde-3-phosphate dehydrogenase (1:5000; Sigma-Aldrich); (viii) rabbit COX-IV (Abcam, Cambridge, UK); and (ix) mouse protein disulphide isomerase (PDI) (1:5000, R&D System, Abingdon, UK). Secondary antibodies for immunofluorescence (Jackson ImmunoResearch, Newmarket, UK) were: (i) antimouse conjugated to Alexa Fluor 488; (ii) anti-rabbit conjugated to Alexa Fluor 488; and (iii) anti-rabbit conjugated to Alexa Fluor 568. Anti-mouse or anti-rabbit antibodies conjugated to horseradish peroxidase (Jackson ImmunoResearch) were used for western blot experiment at 1:5000 dilution.
Statistics
Data, reported as mean + SEM, were statistically evaluated by analysis of variance (ANOVA) (if F reached significance) followed by the Bonferroni test, or by the Student's t-test (software: GraphPad Prism 4.0). P-values less than 0.05 were considered as indicative of significant differences.
Results

Expression of Kv7.4 mRNA and protein in cardiac tissue and cardiomyocytes
qPCR experiments using specific primers (Supplementary material online, Table S1 ) were performed on mRNA extracted from rat brain, heart, and liver. In the brain, Kv7.2 -5 transcripts were readily identified, whereas smaller but detectable amounts of Kv7.1 transcripts were also found ( Figure 1A ). In contrast, mRNAs encoding for Kv7.2-5 were expressed at rather marginal levels in the liver, whereas Kv7.1 transcripts were clearly detected. In cardiac tissue, Kv7.1 showed the highest expression level among Kv7 transcripts, but Kv7.4 transcripts were also found, 12 with expression levels comparable to the brain.
Western blot experiments with anti-Kv7.4 antibodies in total lysates from adult rat heart revealed a band of 77 kDa; this band was present in voltage-dependent anion-selective (VDAC) channel-positive mitochondrial fractions, which tested negative for cytosolic markers such as a-tubulin and GAPDH ( Figure 1B , upper panel). Kv7.4 signals were also readily detected in rat heart mitoplasts, in which the outer mitochondrial membrane (OMM) VDAC signal was markedly decreased ( Figure 1B Figure  S1A ), confirming antibody specificity.
In H9c2 cardiomyoblasts, Kv7.4 antibodies identified a 77 kDa band in mitochondria (positive to cytochrome c oxidase subunit IV, COX-IV), but not in cytoplasmic (tubulin-positive) or microsomal (tubulin-negative) fractions ( Figure 1C) ; a similar subcellular pattern of expression of Kv7.4 subunits was also observed in freshly isolated adult rat cardiac myocytes, in which the Kv7.4-reactive band was mainly found in COX-IV-positive, but GADPH-and PDI-negative, fractions corresponding to mitochondria. In contrast, in cardiac myocytes, a 71 kDa band corresponding to Kv7.1 subunits could be readily detected in the cytosolic fraction; this band was instead absent from the microsomal and mitochondrial fractions ( Figure 1D) . A band of similar molecular mass was revealed in total lysates from Kv7.1-transfected (but not Kv7.2-, Kv7.3-, Kv7.4-, or Kv7.5-transfected or in non-transfected) CHO cells (Supplementary material online, Figure S1B ); this band was not detected in adult rat heart mitochondrial preparations (Supplementary material online, Figure S1C ).
Subcellular localization of Kv7.4 in H9c2 cells, isolated primary rat cardiomyocytes, and adult rat hearts
In H9c2 rat embryonic cardiomyocytes, immunofluorescence experiments revealed that Kv7.4 antibodies stained a network of filamentous structures surrounding the nucleus and spreading throughout the cytosol ( Figure 2A, panel a) ; the same subcellular structures were also labelled by the mitochondria-specific marker Mitotracker ( Figure 2A , panel b; merge image in Figure 2A , panel c). Better resolution was obtained in higher magnification images ( Figure 2A, panels d -f ). In contrast, H9c2 cell staining with antibodies directed against type-1 S1PR1 17 clearly labelled the plasma membrane (indicated by the arrowheads) and the cytoplasm ( Figure 2A , panel h) and did not colocalize with that of Mitotracker (data not shown) or of Kv7.4 antibodies ( Figure 2A, panel g ). Notably, no Kv7.4-specific signal was detected in Mitotracker-labelled mitochondria of non-transfected CHO cells (Supplementary material online, Figure S2 ), arguing against an unspecific targeting of anti-Kv7.4 antibodies to mitochondria. Acutely isolated rat adult primary cardiomyocytes displayed typical rod-like shape and rectangular ends ( Figure 2B , panels a-l). 18 In these cells, Mitotracker (red pseudocolour) stained longitudinal arrays of mitochondria running in parallel with the sarcoplasmic reticulum 19 and clustering around the cell nuclei 20 (arrows in Figure 2B , panels a, d, g, and j). The same structures were also labelled by Kv7.4 antibodies ( Figure 2B , panels b and e), as shown in the merge panels (c and f, at lower and higher magnification, respectively); the Pearson's coefficient for Kv7. 4 and Mitotracker co-localization was 0.33 + 0.01 (n ¼ 4), suggesting that not all mitochondria express a detectable amount of Kv7.4 subunits. Conversely, staining produced by Kv7.1 antibodies was transversely oriented ( Figure 2B , panels h and k) and did not co-localize with Mitotracker ( Figure 2B , panels g and j; merge panels in i and l); the Pearson's coefficient for Kv7.1 and Mitotracker co-localization was 0.02 + 0.02 (n ¼ 4). In rat heart slices, Kv7.4 antibody staining displayed the same longitudinal pattern observed in isolated cardiomyocytes, with positively labelled structures running along the major axis of cardiac fibres and surrounding the contractile myofilaments ( Figure 2B, panel n) . The expression pattern of Kv7.4 subunits overlapped considerably with that of mitochondrial COX-IV ( Figure 2B , panels m and o).
3.3 Subcellular localization of Kv7.4 subunits in adult rat heart detected by immunogold electron microscopy To confirm the localization of Kv7.4 to mitochondria, pre-embedding immunogold electron microscopy experiments were performed in rat adult heart tissue using Kv7.4 antibodies. The upper part of Figure 3 shows four representative images from three different hearts where gold-labelled particles were detected in the mitochondria, as defined by their distinctive cristae. In 138 images analysed, 41.2% of the Kv7.4 channels in rat cardiac mitochondria mitochondria were labelled by gold particles (Figure 3 , lower left panel), a value consistent with immunofluorescence analysis results. In most cases (66.7%, corresponding to 112 mitochondria), labelling was associated with mitochondrial membranes (periphery or cristae), whereas in 22.6% (38 mitochondria) it was predominantly located in the mitochondrial matrix; 10.7% (18 mitochondria) were labelled both at the membrane and intramitochondrial levels ( Figure 3 , lower right panel).
3.4 Effects of Kv7 activators on Tl 1 fluxes, membrane potential, and Ca 21 uptake in isolated rat heart mitochondria Isolated rat heart mitochondria exposed to the K + ionophore valinomycin (2 mM) showed a marked increase in their transmembrane permeability to Tl + . Increasing concentrations of the Kv7.2 -7.5 activators retigabine (1 -30 mM) and flupirtine (30 mM) also promoted Tl + influx; the pEC 50 for retigabine was 5.59 + 0.05 ( Figure 4A ). The initial rate of fluorescence increase induced by valinomycin was 336 + 70 DF/s; those for 1, 3, 10, and 30 mM retigabine rates were 19 + 37, 134 + 33, 151 + 43, and 211 + 41 DF/s, respectively. In heart mitochondria, the effects of retigabine and flupirtine were abrogated by the selective Kv7-blocker XE991 (10 mM), which had no effect on valinomycin-induced Tl + influx ( Figure 4B ). Instead, in mitochondria isolated from rat adult hepatic tissue (where Kv7.4 mRNA levels are virtually undetectable; Figure 1A ), retigabine was ineffective in triggering Tl + influx, whereas valinomycin was still effective ( Figure 4A ). In cardiac, but not in liver, mitochondria, retigabine also produced an XE991 (10 mM)-sensitive concentration-dependent depolarization of the mitochondrial membrane, with a pEC 50 of 5.19 + 0.08 ( Figure 4C) .
Incubation of isolated heart and liver mitochondria in a Ca 2+ -rich solution (100 mM) caused a rapid and almost complete uptake of the cation into the mitochondrial matrix, reducing its extramitochondrial free concentration. In heart mitochondria, this effect was significantly reduced by retigabine (30 mM); XE991 (10 mM) did not influence resting mitochondrial Ca 2+ uptake, but completely antagonized the effects of retigabine. In contrast, retigabine did not influence Ca 2+ uptake in liver mitochondria ( Figure 4D ). Mitochondria labelled with Mitotracker (red in panels a, d, g, and j) were then stained for Kv7.4 (green, panels b and e) or for Kv7.1 (green, panels h and k); nuclei (blue) were counterstained with Hoechst. Merged images are in panels c, f, i, and l. The second and the fourth row sets of panels are higher magnifications of images shown in the first and third rows, respectively. Scale bar is 10 mm (panels c and i) or 5 mm (panels f and l). Arrows: mitochondria. Panels m -o: immunofluorescence in rat cardiac slices incubated with anti-COX-IV (red) and Kv7.4 (green) antibodies; nuclei were counterstained with Hoechst (blue). Scale bar: 10 mm. Experiments were repeated three times, with similar results.
Effects of retigabine on mitochondrial membrane potential, Ca 21 levels, and ROS production in H9c2 cardiomyoblasts
To confirm that Kv7.4 activation could influence mitochondrial function in intact cardiac cells, mitochondrial membrane potential, Ca 2+ levels, and ROS production were measured in intact H9c2 rat cardiomyoblasts. Exposure of H9c2 cells to 30 mM retigabine irreversibly decreased TMRE fluorescence intensity, indicative of mitochondrial depolarization ( Figure 5A and C ), with an efficacy 20% of that of the mitochondrial uncoupler FCCP (1 mM). Retigabine IC 50 was 13.1 + 1.1 mM (n ¼ 6 -11). XE991 (10 mM) did not modify TMRE fluorescence, but largely abolished retigabine induced inhibition of TMRE fluorescence ( Figure 5B and C ).
To assess the specific contribution of mitoKv7.4 channels in retigabine-induced effects on mitochondrial membrane potential, H9c2 cells were transfected with an shRNA targeted against Kv7.4 mRNA (sh-Kv7.4). 15 Western blot experiments confirmed that Kv7.4 expression was reduced to 51.0 + 6.0% (n ¼ 5) in total lysated from shKv7.4-transfected cells (inset in Figure 5D ); a smaller reduction of the Kv7.4 signal was instead observed (74.3 + 3.3%; n ¼ 5) upon transfection with a control plasmid (scr). In shKv7.4-transfected (but not in scr-transfected) H9c2 cells, retigabine (30 mM)-induced inhibition of TMRE fluorescence intensity was decreased when compared with un-transfected H9c2 cells ( Figure 5D and E).
Exposure of H9c2 cells to 30 mM retigabine reversibly decreased X-RHOD-1 fluorescence intensity, suggesting a decrease in mitochondrial Ca 2+ levels ( Figure 6A and B) ; an opposite effect was instead promoted by the mitochondrial uncoupler FCCP (1 mM). XE991 (10 mM) prevented retigabine-induced decrease in X-RHOD-1 fluorescence ( Figure 6B ). Retigabine (30 mM) also increased mitochondrial ROS production in H9c2 cells; XE991 (10 mM) largely prevented retigabine-induced ROS increase ( Figure 6C ). Kv7.4 channels in rat cardiac mitochondria
Effects of retigabine on H9c2 cardiomyoblast survival following A/R
H9c2 cardiomyoblasts exposed to 16 h of anoxia, followed by 2 h of re-oxygenation, exhibited a significant decrease in viability. Preincubation with retigabine (100 mM; applied 1 h before and throughout the anoxic period, but not in the re-oxygenation phase) failed to modify cell viability under normoxic conditions, but significantly increased H9c2 cell survival after the A/R injury. The Kv7 blocker XE991 did not influence cell viability under both normoxic and A/R conditions, but fully antagonized retigabine-induced protection of cardiomyoblasts during A/R ( Figure 7A ). To investigate whether retigabine-induced ROS formation contributed to retigabine-induced cardioprotection, the effect of vitamin E (vitE) was also evaluated. VitE (50 mM) failed to affect cell vitality under normoxic conditions and fully prevented A/R-induced H9c2 cell death, but did not prevent retigabine (100 mM)-induced cytoprotection when incubated 1 h before and together with the Kv7.4 activator (Supplementary material online, Figure S3 ).
Cardioprotective effects exerted by Kv7 channel activation in Langendorff-perfused adult rat hearts
During reperfusion following 30 min of global ischaemia, vehicletreated hearts exhibited a reduction in the inotropic functional parameters. In particular, the RPP and the maximal rate of rise of the LV pressure (dP/dt) always remained lower than the corresponding preischaemic values ( Figure 7B and C, respectively). In vehicle-treated hearts, the CF recorded during the reperfusion time following the ischaemic episode was significantly reduced when compared with the pre-ischaemic phase ( Figure 7D) . Retigabine exposure (100 mM, perfused during the pre-ischaemic phase only) led to an almost complete recovery of the RPP, dP/dt, and CF during reperfusion ( Figure 7B-D) . Morphometric analysis revealed a large decrease in tissue vitality in the LV from I/R-treated hearts (Ai/Alv ¼ 42 + 5%); treatment with retigabine (100 mM) during the pre-ischaemic phase led to a significant reduction of the tissue injury (Ai/Alv ¼ 23 + 1; Figure 7E and F ). In all panels, each data point is the mean + SEM of six experiments run in triplicate, each from mitochondria from a different rat heart. Asterisks indicate significant statistical differences (*P , 0.05 and ***P , 0.001).
Retigabine (100 mM)-induced beneficial effects on functional ( Figure 7B-D) and morphometric ( Figure 7F ) parameters were largely abolished by XE991 (10 mM) pre-treatment. Noteworthy, no significant retigabine-induced cardioprotection was observed when the drug was administered only upon reperfusion, after the ischaemic time; indeed, the functional recovery parameters of RPP and dP/dt were equivalent to those recorded in the vehicle-treated hearts (data not shown), and the morphometric analysis showed high levels of Ai/Alv (37 + 8%; P , 0.05 when compared with retigabine treatment during the pre-ischaemic phase).
Discussion
The fine-tuning of the mitochondrial membrane potential is a critical factor in controlling cell fate during physiological or pathological states, such as myocardial I/R injury, and the pharmacological modulation of mitochondrial ion channels appears as an innovative cardioprotective strategy. In this study, we provide the first evidence that K + channels of the Kv7.4 subclass localize to mitochondria in cardiac myocytes and that their pharmacological activation depolarizes the mitochondrial membrane potential, reduces mitochondrial Ca 2+ uptake, and attenuates damage following an I/R insult. qPCR experiments revealed that the rat heart expressed Kv7.1 transcripts at high levels, a result consistent with the well-described contribution of Kv7.1 subunits to I Ks , the late repolarizing current of the cardiac action potential. 11 In addition, as previously suggested in mouse 12 and zebrafish, 21 moderate levels of Kv7.4 transcripts were also observed in the heart, whereas expression levels of Kv7.2, Kv7.3, and Kv7.5 genes were negligible, suggesting that, in addition to their roles in vascular and non-vascular smooth muscles 10 and in the auditory system, 22 Kv7.4 channels may also play a critical role in cardiac physiology.
Western blot experiments confirmed the abundant expression of Kv7.4 subunits in rat cardiac tissue and revealed that rat heart subcellular fractions highly enriched in mitochondria were intensively positive for Kv7.4 subunits, suggesting their preferential location in mitochondria; experiments in mitoplasts confirmed Kv7.4 subunit expression on the IMM. Rat heart samples used in these experiments likely contain a substantial proportion of vascular tissue, where Kv7.4 channels are known to be expressed 23, 24 ; therefore, similar experiments were also Kv7.4 channels in rat cardiac mitochondria carried out in H9c2 rat cardiomyoblasts 25 and in freshly isolated adult cardiomyocytes. In both cell types, biochemical experiments revealed Kv7.4 subunits mainly in VDAC-or COX-IV-positive mitochondrial fractions.
Immunofluorescence analysis in H9c2 cells confirmed that the Kv7.4 expression pattern overlapped that of the mitochondrial marker Mitotracker and was clearly distinct from a plasma membrane protein such as type-1 S1PR1. 26 In freshly isolated cardiomyocytes, Kv7.4 antibodies also labelled Mitotracker-positive longitudinal structures corresponding to mitochondria running in parallel to their major axis. Consistent with the previous work, 27 Kv7 .1 antibody staining was predominantly transversely oriented, with striations resembling those of the transverse component of the T-tubular system of adult ventricular myocytes. 28 Similarly, immunohistochemical experiments in adult cardiac slices revealed that Kv7.4 displayed a longitudinally oriented punctate staining pattern likely corresponding to single, dot-like mitochondria, 19 similar to that of the mitochondrial marker COX-IV. In the same preparation, electron microscopy confirmed labelling of Kv7.4 subunits in 40% of the mitochondria, with a preferential location on internal (cristae) or peripheral membranes.
To investigate the functional significance of cardiac mitoKv7.4 channels, Kv7 activators (retigabine and flupirtine) and blockers (XE991) were used. Retigabine and flupirtine act on channels formed by all Kv7 subunits, except Kv7.1. 29, 30 In rat heart mitochondria, both retigabine and flupirtine increased Tl + influx, with potency values consistent with their ability to enhance Kv7.4 currents in electrophysiological experiments. 31 The effects of Kv7 activators on Tl + fluxes across heart mitochondrial membranes closely resemble those of the mitoK ATP -opener diazoxide 14, 32 and of naringenin, a mitoBK Ca opener. 16 Noteworthy, XE991 antagonized Tl + influx triggered by retigabine and flupirtine, but not by valinomycin, confirming a specific involvement of Kv7 channels. Retigabine also evoked concentrationdependent and XE991-sensitive mitochondrial depolarization, a result consistent with the recognized effect of an increased IMM K + permeability on mitochondrial membrane potential. 4 The extent of retigabine-induced mitochondrial depolarization is similar to that shown by activators of K ATP channels, such as diazoxide, pinacidil, 33 and benzopyrane-derived selective mitoK ATP openers, as well as by BK Ca openers. 13 Retigabine was also effective in depolarizing the mitochondrial membrane potential in intact H9c2 cells; this effect was blocked by XE991 as well as by reducing Kv7.4 expression with shRNAs, providing genetic evidence for a specific role for Kv7.4 channels in the pharmacological effects herein described. Mitochondria avidly accumulate Ca 2+ ions into the matrix, thus buffering excessive increases in free cytosolic Ca 2+ . 34 Both in isolated mitochondria and in intact H9c2 cells, retigabine decreased mitochondrial Ca 2+ uptake in an XE991-sensitive manner, suggesting that even relatively small positive shifts of the mitochondrial potential substantially reduce Ca 2+ uptake. 13 In mitochondria isolated from hepatic tissue, in which Kv7.4 mRNA levels were almost undetectable, retigabine failed to affect Tl + fluxes, mitochondrial membrane potential, and Ca 2+ uptake, suggesting that retigabineevoked effects in cardiac mitochondria are selectively mediated by Kv7.4 channels. Activation of mitochondrial K + channels such as mitoK ATP , mitoSK Ca , and mitoBK Ca promotes protective effects against cardiac ischaemic injury. 1 In cultured H9c2 cells exposed to A/R, retigabine attenuated cell injury and XE991 antagonized the protective effects of the Kv7 activator. Noteworthy, neither retigabine nor XE991 influenced the viability of H9c2 cells exposed to the normoxic environment, suggesting specific anti-ischaemic mechanisms of protection involving the activation of Kv7 channels. In H9c2 cells, retigabine increased ROS formation, a result lending support to the hypothesis that an initial K + entry via mitoKv7.4, by promoting a mild oxidative stress, would prevent opening of the mitochondrial permeability transition pore and decrease anoxic cell death. 35 However, vitE did not prevent retigabine-induced H9c2 cardioprotective effects; although this result seems to suggest that retigabine-induced cytoprotection is not directly caused by an increased ROS production, vitE likely targets a myriad of molecular steps triggered by A/R, hampering a potential inhibition of retigabine-induced cytoprotection. In Langendorff-perfused rat hearts submitted to I/R, retigabine added during the pre-ischaemic phase improved all the functional and morphological parameters of post-ischaemic recovery; also these effects were fully abolished by XE991. However, these results need to be interpreted with caution, as sarcolemmal Kv7.4 channels identified in the vascular smooth muscle of rat coronary arteries mediate significant vasorelaxing actions, 36 which may participate in the observed cardioprotective effects. However, retigabine-induced functional and structural protection was assessed after 2 h of drug-free postischaemic recovery, suggesting a major contribution of retigabinesensitive cardiac mitoKv7.4 channels in cardioprotection against I/R. This view seems to be confirmed by the observation that retigabine was ineffective when administered only upon reperfusion; however, further experiments are needed to dissect the relative contribution of Kv7.4 channels in cardiomyocytes and/or vascular smooth muscle cells in cardioprotection triggered by the Kv7.4 activator. The fact that retigabine-induced beneficial effects required drug concentrations higher than those affecting mitochondrial function may reflect a limited drug delivery to the mitochondrial target across the plasma membrane. Overall, the results obtained demonstrate that rat cardiomyocytes express mitochondrial Kv7.4 channels which, by regulating membrane potential, influence mitochondrial Ca 2+ permeability. The pharmacological activation of myocardial mitoKv7.4 channel promotes structural and functional recovery following I/R injury, highlighting new and appealing therapeutic strategies for cardioprotection.
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Figure 7
Retigabine-induced cardioprotection in in vitro anoxia and ex vivo ischaemia models. (A) Viability of H9c2 cardiomyoblasts exposed to normoxic conditions (black columns) or to A/R (white columns) treated with: vehicle (Ctl), retigabine (Ret, 100 mM), XE991 (10 mM), and retigabine 100 mM plus XE991 10 mM (Ret + XE991), expressed as percentage of vehicle-treated cells exposed to normoxic conditions. Asterisks indicate significant statistical differences (*P , 0.05 and ***P , 0.001; one-way ANOVA). Data are from six experiments, each performed in triplicate. Time course of RPP [rate × pressure product (B)], dP/dt (C ), and CF (D) in Langendorff-perfused hearts treated with vehicle, retigabine (100 mM), or retigabine (100 mM) plus XE991 (10 mM). Data are expressed as percentage of the respective values recorded in the pre-ischaemic phase. In (B -D), two-way ANOVA indicated that the vehicle and retigabine curves exhibit highly significant (***P , 0.001) differences. (E) Representative images of LV slices from vehicle-or retigabine-treated (100 mM) hearts after I/R. (F) Quantification of the extension of the ischaemic damage (white/pale regions), expressed as percentage of the LV slice area (Ai/Alv) in the indicated groups. Asterisk indicates a statistically significant difference (*P , 0.05). Data are from six to eight experiments, each performed in different animals.
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